Social Media Ideas for Gnpx

Latest updates for Gnpx

Fresh curated links around GNPX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

finance.yahoo.com /3 weeks ago

Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS

Read source

seekingalpha.com /1 month ago

Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS Inhibitor Combination...

Read source

newswire.com /1 week ago

GPOPlus+ (OTCQB:GPOX) Launches GPOX Pulse to Give Investors Direct Access to Company News, SEC Filings and Weekly Busine...

Subscribe today to receive Issue 01 | The America 250 Inaugural Issue. Shareholders and investors can now sign up for free email, SMS alerts and browser notifications at GPOPlus.co...

Read source

seekingalpha.com /1 month ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

Read source

seekingalpha.com /1 day ago

Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin

Read source

seekingalpha.com /1 month ago

Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS Inhibitor Combination...

Read source

cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source

seekingalpha.com /1 month ago

Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg...

Read source

cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source

seekingalpha.com /2 weeks ago

Sanofi's Nexviazyme hits primary goal in Pompe disease study

Read source

seekingalpha.com /1 month ago

GPIX: Covered Call ETF On S&P 500 Among Top Performers And The Difference

Read source

fiercebiotech.com /1 month ago

Galmed acquires Colospan in $4.5M deal as it eyes $6B GI dx market

Galmed Pharmaceuticals acquired Colospan in a $4.5 million million deal as the Israel-based biotech looks to create a gastrointestinal platform targeting a dx sector valued at $6 b...

Read source

pharmexec.com /1 month ago

<![CDATA[Inside the Expert Network Guiding TGN-S15 to Market]]>

Read source

biopharmadive.com /1 month ago

Otsuka showcases kidney drug data; Pfizer cuts an AI deal

Voyxact helped preserve kidney function, but left an opening for competing IgAN drugs from Vera and Vertex. Elsewhere, Takeda’s alliance with Innovent paid early dividends and Axso...

Read source

fool.com /1 month ago

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million

This clinical-stage biotech develops oral therapeutics for chronic diseases, with a pipeline centered on metabolic and pulmonary targets.

Read source

seekingalpha.com /1 month ago

NextCure, Inc. (NXTC) Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Se...

Read source

newswire.com /1 week ago

Pomerantz LLP Advises Shareholders of Class Action Against Genius Group Limited – GNS

Read source

biopharmadive.com /2 days ago

Agenus surges on study pivot; Apnimed lines up an IPO

Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA...

Read source

newswire.com /1 week ago

Pomerantz LLP Advises Shareholders of Class Action Involving Genius Group Limited – GNS

Read source

newswire.com /1 week ago

Pomerantz LLP Advises Shareholders of Class Action Involving Genius Group Limited – GNS

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.